 | • レポートコード：QAF27747 • 出版社/出版日：QYResearch / 2021年3月31日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の静注用免疫グロブリン（IVIg）市場について種類別（IVIg液、IVIg粉）、用途別（免疫不全症、自己免疫疾患、急性感染症）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・静注用免疫グロブリン（IVIg）市場の概要 ・世界の主要地域別静注用免疫グロブリン（IVIg）市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の静注用免疫グロブリン（IVIg）市場規模2016-2021：種類別（IVIg液、IVIg粉） ・世界の静注用免疫グロブリン（IVIg）市場予測2012-2027：種類別（IVIg液、IVIg粉） ・世界の静注用免疫グロブリン（IVIg）市場規模2016-2021：用途別（免疫不全症、自己免疫疾患、急性感染症） ・世界の静注用免疫グロブリン（IVIg）市場予測2012-2027：用途別（免疫不全症、自己免疫疾患、急性感染症） ・静注用免疫グロブリン（IVIg）のアメリカ市場規模と予測2016-2021 ・静注用免疫グロブリン（IVIg）のヨーロッパ市場規模と予測2016-2021 ・静注用免疫グロブリン（IVIg）の中国市場規模と予測2016-2021 ・静注用免疫グロブリン（IVIg）の日本市場規模と予測2016-2021 ・静注用免疫グロブリン（IVIg）の東南アジア市場規模と予測2016-2021 ・静注用免疫グロブリン（IVIg）のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Baxter、Grifols、CSL、Octapharma、Biotest、Kedrion、Hualan Bio、CNBG、Shanghai RAAS、CBPO、LFB Group、BPL、Sichuan Yuanda Shuyang） ・静注用免疫グロブリン（IVIg）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・静注用免疫グロブリン（IVIg）の市場動向・機会・課題 ・調査の結論 |
Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.
North America region is the largest supplier of intravenous immunoglobulin (IVIg), with a production market share nearly 48% in 2016. Europe is the second largest supplier of intravenous immunoglobulin (IVIg), enjoying production market share nearly 23% in 2016.
North America is the largest sales place, with a sales market share nearly 44% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 22%.
Market competition is intense. Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Intravenous Immunoglobulin (IVIg) Market
The global Intravenous Immunoglobulin (IVIg) market was valued at US$ 10310 in 2020 and will reach US$ 14540 million by the end of 2027, growing at a CAGR of 5.9% during 2022-2027.
Global Intravenous Immunoglobulin (IVIg) Scope and Market Size
The global Intravenous Immunoglobulin (IVIg) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous Immunoglobulin (IVIg) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
The Intravenous Immunoglobulin (IVIg) market is analysed and market size information is provided by regions (countries). Segment by Application, the Intravenous Immunoglobulin (IVIg) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
1 Intravenous Immunoglobulin (IVIg) Market Overview
1.1 Intravenous Immunoglobulin (IVIg) Product Scope
1.2 Intravenous Immunoglobulin (IVIg) Segment by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2016 & 2021 & 2027)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Intravenous Immunoglobulin (IVIg) Segment by Application
1.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Intravenous Immunoglobulin (IVIg) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Intravenous Immunoglobulin (IVIg) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Intravenous Immunoglobulin (IVIg) Price Trends (2016-2027)
2 Intravenous Immunoglobulin (IVIg) Estimates and Forecasts by Region
2.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Intravenous Immunoglobulin (IVIg) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)
2.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2016-2021)
2.3 Global Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Intravenous Immunoglobulin (IVIg) Estimates and Projections (2016-2027)
2.4.2 Europe Intravenous Immunoglobulin (IVIg) Estimates and Projections (2016-2027)
2.4.3 China Intravenous Immunoglobulin (IVIg) Estimates and Projections (2016-2027)
2.4.4 Japan Intravenous Immunoglobulin (IVIg) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Intravenous Immunoglobulin (IVIg) Estimates and Projections (2016-2027)
2.4.6 India Intravenous Immunoglobulin (IVIg) Estimates and Projections (2016-2027)
3 Global Intravenous Immunoglobulin (IVIg) Competition Landscape by Players
3.1 Global Top Intravenous Immunoglobulin (IVIg) Players by Sales (2016-2021)
3.2 Global Top Intravenous Immunoglobulin (IVIg) Players by Revenue (2016-2021)
3.3 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2020)
3.4 Global Intravenous Immunoglobulin (IVIg) Average Price by Company (2016-2021)
3.5 Manufacturers Intravenous Immunoglobulin (IVIg) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Intravenous Immunoglobulin (IVIg) Market Size by Type
4.1 Global Intravenous Immunoglobulin (IVIg) Historic Market Review by Type (2016-2021)
4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2016-2021)
4.1.3 Global Intravenous Immunoglobulin (IVIg) Price by Type (2016-2021)
4.2 Global Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2022-2027)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2022-2027)
4.2.3 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Type (2022-2027)
5 Global Intravenous Immunoglobulin (IVIg) Market Size by Application
5.1 Global Intravenous Immunoglobulin (IVIg) Historic Market Review by Application (2016-2021)
5.1.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
5.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2016-2021)
5.1.3 Global Intravenous Immunoglobulin (IVIg) Price by Application (2016-2021)
5.2 Global Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2022-2027)
5.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2022-2027)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Application (2022-2027)
6 North America Intravenous Immunoglobulin (IVIg) Market Facts & Figures
6.1 North America Intravenous Immunoglobulin (IVIg) Sales by Company
6.1.1 North America Intravenous Immunoglobulin (IVIg) Sales by Company (2016-2021)
6.1.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021)
6.2 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
6.2.1 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2016-2021)
6.2.2 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2022-2027)
6.3 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
6.3.1 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2016-2021)
6.3.2 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2022-2027)
7 Europe Intravenous Immunoglobulin (IVIg) Market Facts & Figures
7.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Company
7.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Company (2016-2021)
7.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021)
7.2 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
7.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2022-2027)
7.3 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
7.3.1 Europe 144 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 144 Sales Breakdown by Application (2022-2027)
8 China Intravenous Immunoglobulin (IVIg) Market Facts & Figures
8.1 China Intravenous Immunoglobulin (IVIg) Sales by Company
8.1.1 China Intravenous Immunoglobulin (IVIg) Sales by Company (2016-2021)
8.1.2 China Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021)
8.2 China Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
8.2.1 China Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2016-2021)
8.2.2 China Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2022-2027)
8.3 China Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Intravenous Immunoglobulin (IVIg) Market Facts & Figures
9.1 Japan Intravenous Immunoglobulin (IVIg) Sales by Company
9.1.1 Japan Intravenous Immunoglobulin (IVIg) Sales by Company (2016-2021)
9.1.2 Japan Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021)
9.2 Japan Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
9.2.1 Japan Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2022-2027)
9.3 Japan Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Intravenous Immunoglobulin (IVIg) Market Facts & Figures
10.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales by Company
10.1.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales by Company (2016-2021)
10.1.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021)
10.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
10.2.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
10.3.1 Southeast Asia K Bottle Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Bottle Sales Breakdown by Application (2022-2027)
11 India Intravenous Immunoglobulin (IVIg) Market Facts & Figures
11.1 India Intravenous Immunoglobulin (IVIg) Sales by Company
11.1.1 India Intravenous Immunoglobulin (IVIg) Sales by Company (2016-2021)
11.1.2 India Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021)
11.2 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
11.2.1 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2016-2021)
11.2.2 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2022-2027)
11.3 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
11.3.1 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2016-2021)
11.3.2 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Intravenous Immunoglobulin (IVIg) Business
12.1 Baxter
12.1.1 Baxter Corporation Information
12.1.2 Baxter Business Overview
12.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Baxter Intravenous Immunoglobulin (IVIg) Products Offered
12.1.5 Baxter Recent Development
12.2 Grifols
12.2.1 Grifols Corporation Information
12.2.2 Grifols Business Overview
12.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Grifols Intravenous Immunoglobulin (IVIg) Products Offered
12.2.5 Grifols Recent Development
12.3 CSL
12.3.1 CSL Corporation Information
12.3.2 CSL Business Overview
12.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CSL Intravenous Immunoglobulin (IVIg) Products Offered
12.3.5 CSL Recent Development
12.4 Octapharma
12.4.1 Octapharma Corporation Information
12.4.2 Octapharma Business Overview
12.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Products Offered
12.4.5 Octapharma Recent Development
12.5 Biotest
12.5.1 Biotest Corporation Information
12.5.2 Biotest Business Overview
12.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Biotest Intravenous Immunoglobulin (IVIg) Products Offered
12.5.5 Biotest Recent Development
12.6 Kedrion
12.6.1 Kedrion Corporation Information
12.6.2 Kedrion Business Overview
12.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Products Offered
12.6.5 Kedrion Recent Development
12.7 Hualan Bio
12.7.1 Hualan Bio Corporation Information
12.7.2 Hualan Bio Business Overview
12.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Products Offered
12.7.5 Hualan Bio Recent Development
12.8 CNBG
12.8.1 CNBG Corporation Information
12.8.2 CNBG Business Overview
12.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CNBG Intravenous Immunoglobulin (IVIg) Products Offered
12.8.5 CNBG Recent Development
12.9 Shanghai RAAS
12.9.1 Shanghai RAAS Corporation Information
12.9.2 Shanghai RAAS Business Overview
12.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Products Offered
12.9.5 Shanghai RAAS Recent Development
12.10 CBPO
12.10.1 CBPO Corporation Information
12.10.2 CBPO Business Overview
12.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 CBPO Intravenous Immunoglobulin (IVIg) Products Offered
12.10.5 CBPO Recent Development
12.11 LFB Group
12.11.1 LFB Group Corporation Information
12.11.2 LFB Group Business Overview
12.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Products Offered
12.11.5 LFB Group Recent Development
12.12 BPL
12.12.1 BPL Corporation Information
12.12.2 BPL Business Overview
12.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 BPL Intravenous Immunoglobulin (IVIg) Products Offered
12.12.5 BPL Recent Development
12.13 Sichuan Yuanda Shuyang
12.13.1 Sichuan Yuanda Shuyang Corporation Information
12.13.2 Sichuan Yuanda Shuyang Business Overview
12.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Products Offered
12.13.5 Sichuan Yuanda Shuyang Recent Development
13 Intravenous Immunoglobulin (IVIg) Manufacturing Cost Analysis
13.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
13.4 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Intravenous Immunoglobulin (IVIg) Distributors List
14.3 Intravenous Immunoglobulin (IVIg) Customers
15 Market Dynamics
15.1 Intravenous Immunoglobulin (IVIg) Market Trends
15.2 Intravenous Immunoglobulin (IVIg) Drivers
15.3 Intravenous Immunoglobulin (IVIg) Market Challenges
15.4 Intravenous Immunoglobulin (IVIg) Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Intravenous Immunoglobulin (IVIg) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Intravenous Immunoglobulin (IVIg) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Intravenous Immunoglobulin (IVIg) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Region (2016-2021)
Table 5. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)
Table 6. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Region (2016-2021)
Table 8. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Forecast by Region (2022-2027)
Table 9. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Intravenous Immunoglobulin (IVIg) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) of Key Companies (2016-2021)
Table 13. Global Intravenous Immunoglobulin (IVIg) Sales Share by Company (2016-2021)
Table 14. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Company (2016-2021)
Table 16. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2020)
Table 17. Global Intravenous Immunoglobulin (IVIg) Average Price (USD/Bottle) of Key Company (2016-2021)
Table 18. Manufacturers Intravenous Immunoglobulin (IVIg) Manufacturing Sites and Area Served
Table 19. Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2016-2021)
Table 22. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2016-2021)
Table 23. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2016-2021)
Table 25. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2022-2027)
Table 26. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2022-2027)
Table 28. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2022-2027)
Table 29. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2016-2021)
Table 30. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2016-2021)
Table 31. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2016-2021)
Table 33. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2022-2027)
Table 34. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2022-2027)
Table 35. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2022-2027)
Table 37. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2022-2027)
Table 38. North America Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2016-2021)
Table 39. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2016-2021)
Table 40. North America Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2016-2021)
Table 42. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 43. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 44. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 45. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2022-2027)
Table 46. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 47. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 48. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 49. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2022-2027)
Table 50. Europe Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2016-2021)
Table 51. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2016-2021)
Table 52. Europe Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2016-2021)
Table 54. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 55. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 56. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 57. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2022-2027)
Table 58. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 59. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 60. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 61. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2022-2027)
Table 62. China Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2016-2021)
Table 63. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2016-2021)
Table 64. China Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2016-2021)
Table 66. China Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 67. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 68. China Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 69. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2022-2027)
Table 70. China Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 71. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 72. China Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 73. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2022-2027)
Table 74. Japan Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2016-2021)
Table 75. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2016-2021)
Table 76. Japan Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2016-2021)
Table 78. Japan Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 79. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 80. Japan Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 81. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2022-2027)
Table 82. Japan Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 83. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 84. Japan Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 85. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2016-2021)
Table 87. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 91. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 93. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 95. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 97. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2022-2027)
Table 98. India Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Company (2016-2021)
Table 99. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2016-2021)
Table 100. India Intravenous Immunoglobulin (IVIg) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2016-2021)
Table 102. India Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 103. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Table 104. India Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 105. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2022-2027)
Table 106. India Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 107. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Table 108. India Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 109. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2022-2027)
Table 110. Baxter Corporation Information
Table 111. Baxter Description and Business Overview
Table 112. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 113. Baxter Intravenous Immunoglobulin (IVIg) Product
Table 114. Baxter Recent Development
Table 115. Grifols Corporation Information
Table 116. Grifols Description and Business Overview
Table 117. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 118. Grifols Intravenous Immunoglobulin (IVIg) Product
Table 119. Grifols Recent Development
Table 120. CSL Corporation Information
Table 121. CSL Description and Business Overview
Table 122. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 123. CSL Intravenous Immunoglobulin (IVIg) Product
Table 124. CSL Recent Development
Table 125. Octapharma Corporation Information
Table 126. Octapharma Description and Business Overview
Table 127. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 128. Octapharma Intravenous Immunoglobulin (IVIg) Product
Table 129. Octapharma Recent Development
Table 130. Biotest Corporation Information
Table 131. Biotest Description and Business Overview
Table 132. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 133. Biotest Intravenous Immunoglobulin (IVIg) Product
Table 134. Biotest Recent Development
Table 135. Kedrion Corporation Information
Table 136. Kedrion Description and Business Overview
Table 137. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 138. Kedrion Intravenous Immunoglobulin (IVIg) Product
Table 139. Kedrion Recent Development
Table 140. Hualan Bio Corporation Information
Table 141. Hualan Bio Description and Business Overview
Table 142. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 143. Hualan Bio Intravenous Immunoglobulin (IVIg) Product
Table 144. Hualan Bio Recent Development
Table 145. CNBG Corporation Information
Table 146. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 147. CNBG Description and Business Overview
Table 148. CNBG Intravenous Immunoglobulin (IVIg) Product
Table 149. CNBG Recent Development
Table 150. Shanghai RAAS Corporation Information
Table 151. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 152. Shanghai RAAS Description and Business Overview
Table 153. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product
Table 154. Shanghai RAAS Recent Development
Table 155. CBPO Corporation Information
Table 156. CBPO Description and Business Overview
Table 157. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 158. CBPO Intravenous Immunoglobulin (IVIg) Product
Table 159. CBPO Recent Development
Table 160. LFB Group Corporation Information
Table 161. LFB Group Description and Business Overview
Table 162. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 163. LFB Group Intravenous Immunoglobulin (IVIg) Product
Table 164. LFB Group Recent Development
Table 165. BPL Corporation Information
Table 166. BPL Description and Business Overview
Table 167. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 168. BPL Intravenous Immunoglobulin (IVIg) Product
Table 169. BPL Recent Development
Table 170. Sichuan Yuanda Shuyang Corporation Information
Table 171. Sichuan Yuanda Shuyang Description and Business Overview
Table 172. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million USD), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 173. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product
Table 174. Sichuan Yuanda Shuyang Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Intravenous Immunoglobulin (IVIg) Distributors List
Table 178. Intravenous Immunoglobulin (IVIg) Customers List
Table 179. Intravenous Immunoglobulin (IVIg) Market Trends
Table 180. Intravenous Immunoglobulin (IVIg) Market Drivers
Table 181. Intravenous Immunoglobulin (IVIg) Market Challenges
Table 182. Intravenous Immunoglobulin (IVIg) Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Immunoglobulin (IVIg) Product Picture
Figure 2. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2021 & 2027
Figure 6. Immunodeficiency Examples
Figure 7. Autoimmune Disease Examples
Figure 8. Acute Infection Examples
Figure 9. Global Intravenous Immunoglobulin (IVIg) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Growth Rate (2016-2027)
Figure 12. Global Intravenous Immunoglobulin (IVIg) Price Trends Growth Rate (2016-2027) (USD/Bottle)
Figure 13. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Growth Rate (2016-2027)
Figure 17. Europe Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Intravenous Immunoglobulin (IVIg) Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Intravenous Immunoglobulin (IVIg) Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Intravenous Immunoglobulin (IVIg) Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Intravenous Immunoglobulin (IVIg) Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue in Intravenous Immunoglobulin (IVIg): 2016 & 2020
Figure 28. Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2016-2021)
Figure 30. Global Intravenous Immunoglobulin (IVIg) Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2016-2021)
Figure 32. Global Intravenous Immunoglobulin (IVIg) Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020
Figure 34. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020
Figure 35. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020
Figure 36. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020
Figure 37. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020
Figure 38. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020
Figure 39. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020
Figure 40. Japan Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020
Figure 41. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020
Figure 42. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020
Figure 43. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020
Figure 44. India Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Intravenous Immunoglobulin (IVIg)
Figure 47. Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
Figure 48. Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
IVIg粉末のグローバル市場調査 2019年 The global IVIg Powder market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on IVIg Powder volume and value at global level, regional level and company level. From a global perspective, this report represen…- IVIGのグローバル市場調査 2019年 The global IVIG market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on IVIG volume and value at global level, regional level and company level. From a global perspective, this report represents overall IVI…
- 世界の低親和性免疫グロブリンガンマFc領域受容体II-B市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market The global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…
- 人間狂犬病免疫グロブリン（IM）のグローバル市場2021 Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation …
- ヒト破傷風免疫グロブリンのグローバル市場調査 2019年 The global Human Tetanus Immunoglobulin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Human Tetanus Immunoglobulin volume and value at global level, regional level and company level. From a global…